Tatva Chintan Pharma Chem Limited Cash Flow Conversion Efficiency
Tatva Chintan Pharma Chem Limited cash flow conversion efficiency. Based on the latest financial reports, Tatva Chintan Pharma Chem Limited (TATVA) has a cash flow conversion efficiency ratio of 0.019x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs135.54 Million ≈ $1.47 Million USD) by net assets (Rs7.27 Billion ≈ $78.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Tatva Chintan Pharma Chem Limited (2018–2025)
Cash flow conversion efficiency of Tatva Chintan Pharma Chem Limited from 2018 to 2025. This chart illustrates how Tatva Chintan Pharma Chem Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Tatva Chintan Pharma Chem Limited share price for real-time trading data and today's change.
Tatva Chintan Pharma Chem Limited Cash Flow Conversion Ratio Explained
Tatva Chintan Pharma Chem Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Tatva Chintan Pharma Chem Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tatva Chintan Pharma Chem Limited ranked by their cash flow conversion efficiency. Also see TATVA company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Precious Shipping Public Company Limited
BK:PSL
|
0.038x |
|
Shanghai Rongtai Health Tech
SHG:603579
|
-0.007x |
|
PCL Technologies Inc
TW:4977
|
0.004x |
|
Hansa Biopharma AB
ST:HNSA
|
0.253x |
|
Malteries Franco-Belges Société Anonyme
PA:MALT
|
0.007x |
|
Hoang Huy Investment Financial
VN:TCH
|
0.067x |
|
Bandwidth Inc
NASDAQ:BAND
|
0.057x |
|
RADIANCE HLDGS GRP.HD-01
F:RDH
|
N/A |
Annual Cash Flow Conversion Efficiency for Tatva Chintan Pharma Chem Limited (2018–2025)
The table below shows the annual cash flow conversion efficiency of Tatva Chintan Pharma Chem Limited from 2018 to 2025. Review TATVA free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs7.39 Billion ≈ $79.90 Million |
Rs246.71 Million ≈ $2.67 Million |
0.033x | -74.90% |
| 2024-03-31 | Rs7.37 Billion ≈ $79.71 Million |
Rs980.44 Million ≈ $10.60 Million |
0.133x | +146.47% |
| 2023-03-31 | Rs5.15 Billion ≈ $55.67 Million |
Rs277.83 Million ≈ $3.00 Million |
0.054x | +25.29% |
| 2022-03-31 | Rs4.73 Billion ≈ $51.16 Million |
Rs203.78 Million ≈ $2.20 Million |
0.043x | -70.60% |
| 2021-03-31 | Rs1.66 Billion ≈ $17.95 Million |
Rs243.19 Million ≈ $2.63 Million |
0.147x | -31.87% |
| 2020-03-31 | Rs1.18 Billion ≈ $12.73 Million |
Rs253.12 Million ≈ $2.74 Million |
0.215x | +133.02% |
| 2019-03-31 | Rs797.00 Million ≈ $8.62 Million |
Rs73.56 Million ≈ $795.52K |
0.092x | -47.56% |
| 2018-03-31 | Rs591.56 Million ≈ $6.40 Million |
Rs104.12 Million ≈ $1.13 Million |
0.176x | -- |
About Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited engages in the manufacture and sale of specialty chemicals in India, Germany, the United States of America, China, Singapore, and internationally. It offers structure directing agents (SDAs); phase transfer catalysts (PTCs); electrolyte salts for super capacitor batteries; pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC); and br… Read more